3Christ-Crain M,Morgenthaler NG,Struck J,et al.Mid-regional pro-ADM as a prognostic marker in sepsis:an observational study[J].Crit Care,2005,9(6):816 -824. 被引量：1
4Bone RC,Balk RA,Cerra FB,et al.Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.The ACCP/SCCM consensus Conference Committee.American College of Chest Physicians/Society of Critical Care Medicine[J].Chest,1992,101:1644-1665. 被引量：1
5Emanuel P,Lauralyn McIntyre,David C,et al.Early and innovative inter vention for severe sepsis and septic shock:taking advantage of a window of opportunity[J].CMAJ,2005,10 (25):173-179. 被引量：1
6Karimova A,Pinsky DJ.The endothelial response to oxygen deprivation:biology and clinical implications[J].Intensive Care Med,2001,27:19 -31. 被引量：1
7Reinhart K,Kuhn HJ,Hartog C,et al.Continuous central venous and pulmonary artery oxygen saturation monitoring in the critically ill[J].Intensive Care Med,2004,30:1572-1578. 被引量：1
8Astiz ME,Rackow EC,Kaufman B,et al.Relationship of oxygen delivery and mixed venous oxygenation to lactic acidosis in patients with sepsis and acute myocardial infarction[J].Crit Care Med,1988,16:655 -658. 被引量：1
9Lundberg JS,Perl TM,Wiblin T,et al.Septic shock:an analysis of outcomes for patients with onset on hospital wards versus intensive care units[J].Crit Care Med,1998,26:1020-1024. 被引量：1
10Rivers E,Nguyen B,Havstad S,et al.Early goal-directed therapy in the treatment of severe sepsis and septic shock[J].N Engl J Med,2001,345:1368-1377. 被引量：1
